133 related articles for article (PubMed ID: 6601707)
21. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
[TBL] [Abstract][Full Text] [Related]
22. Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.
Hamuro J; Hadding U; Bitter-Suermann D
Immunology; 1978 Apr; 34(4):695-705. PubMed ID: 721136
[TBL] [Abstract][Full Text] [Related]
23. Activation of the classical complement pathway by a polysaccharide from sugar cane.
Li X; Vogt W
Immunopharmacology; 1982 Oct; 5(1):31-8. PubMed ID: 6813288
[TBL] [Abstract][Full Text] [Related]
24. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives.
Honda S; Sugino H; Asano T; Kakinuma A
Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648
[TBL] [Abstract][Full Text] [Related]
25. Lysosomal enzyme release from human monocytes by particulate activators is mediated by beta-glucan inhibitable receptors.
Janusz MJ; Austen KF; Czop JK
J Immunol; 1987 Jun; 138(11):3897-901. PubMed ID: 3035014
[TBL] [Abstract][Full Text] [Related]
26. Classical pathway of complement activation in mammalian kidneys.
Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
[TBL] [Abstract][Full Text] [Related]
27. Curdlan, a (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO13140, activates the alternative complement pathway by heat treatment.
Matsushita M
Immunol Lett; 1990 Oct; 26(1):95-7. PubMed ID: 2276766
[TBL] [Abstract][Full Text] [Related]
28. Soluble beta-1,3/1,6-glucan from yeast inhibits experimental periodontal disease in Wistar rats.
Breivik T; Opstad PK; Engstad R; Gundersen G; Gjermo P; Preus H
J Clin Periodontol; 2005 Apr; 32(4):347-52. PubMed ID: 15811050
[TBL] [Abstract][Full Text] [Related]
29. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
[TBL] [Abstract][Full Text] [Related]
30. Evidence for involvement of beta-glucan-binding cell surface lectins in human natural killer cell function.
Duan X; Ackerly M; Vivier E; Anderson P
Cell Immunol; 1994 Sep; 157(2):393-402. PubMed ID: 8069924
[TBL] [Abstract][Full Text] [Related]
31. [Immunopharmacologic study in mice of 2 beta-1, 3, beta-1, 6 polysaccharides (scleroglucan and PSAT) on the activation of macrophages and T lymphocytes].
Bousquet M; Escoula L; Peurière S; Pipy B; Roubinet F; Chavant C
Ann Rech Vet; 1989; 20(2):165-73. PubMed ID: 2787614
[TBL] [Abstract][Full Text] [Related]
32. [Role of the classical and alternative complement pathways in chemotaxis of human C2 deficiency (author's transl)].
Pham Huu T; Buriot D; Griscelli C
Ann Immunol (Paris); 1980; 131C(1):69-77. PubMed ID: 7396417
[TBL] [Abstract][Full Text] [Related]
33. The role of complement in glucan-induced protection against septic shock.
Williams DL; Sherwood ER; Browder IW; McNamee RB; Jones EL; Di Luzio NR
Circ Shock; 1988 May; 25(1):53-60. PubMed ID: 3042187
[TBL] [Abstract][Full Text] [Related]
34. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
[TBL] [Abstract][Full Text] [Related]
35. Effects of particulate and soluble (1-3)-beta-glucans on Ca2+ influx in NR8383 alveolar macrophages.
Mörk AC; Helmke RJ; Martinez JR; Michalek MT; Patchen ML; Zhang GH
Immunopharmacology; 1998 Jul; 40(1):77-89. PubMed ID: 9776481
[TBL] [Abstract][Full Text] [Related]
36. Interactions of chrysotile asbestos fibres with the complement system.
Saint-Remy JM; Cole P
Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
[TBL] [Abstract][Full Text] [Related]
37. Effects of beta-glucan extracted from Saccharomyces cerevisiae on growth performance, and immunological and somatotropic responses of pigs challenged with Escherichia coli lipopolysaccharide.
Li J; Li DF; Xing JJ; Cheng ZB; Lai CH
J Anim Sci; 2006 Sep; 84(9):2374-81. PubMed ID: 16908640
[TBL] [Abstract][Full Text] [Related]
38. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
[TBL] [Abstract][Full Text] [Related]
39. Fungal beta-(1-3)-D-glucan derivatives exhibit high antioxidative and antimutagenic activity in vitro.
Krizková L; Duracková Z; Sandula J; Slamenová D; Sasinková V; Sivonová M; Krajcovic J
Anticancer Res; 2003; 23(3B):2751-6. PubMed ID: 12894570
[TBL] [Abstract][Full Text] [Related]
40. Complement activation by aluminium and zirconium compounds.
Ramanathan VD; Badenoch-Jones P; Turk JL
Immunology; 1979 Aug; 37(4):881-8. PubMed ID: 500133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
